About

Ibogaine Canada is an independent information resource on ibogaine for people researching ibogaine. Our mission: to provide evidence-first, practical, and legally-aware information focused on safety, clarity and context — not clinical services or advice.

We are independent, plainspoken and committed to transparent sourcing. If you'd like an overview of what the site covers and how we vet material, read on.

Explore the site

A folded regulatory document spread on a textured surface accompanied by notes, reflecting regulatory status research

Our editorial approach

We curate and synthesise public information so readers can find factual, verifiable context about ibogaine in the Canadian setting. We do not provide medical, legal, or treatment services; our role is informational and educational.

Sourcing

We prioritise primary sources where possible — official guidance, peer-reviewed literature, and public registries — then add explanatory synthesis for readers. For example, claims about legal frameworks are checked against government pages such as Health Canada guidance.

Verification

Statements are cross-checked across multiple independent sources. Where evidence is limited or evolving we flag uncertainty rather than make definitive clinical claims; that approach follows standards recommended by institutions such as evidence-based practice.

Updates

We keep policy and safety pages current as new material appears. When content references facility listings or directories, we rely on public registries and explicit provider disclosures.

What we cover

Our scope is editorial and practical: we explain how information is organised on the site, the types of pages you will find, and the editorial boundaries we maintain.

Typical content areas

Summaries of legal and regulatory context for Canadians, framed with official sources.
Plain-language explanations of safety considerations and risk-management resources.
Guidance on how to locate clinical trials or research listings relevant to Canada.
Editorial notes explaining how and why a piece was updated or changed.

If you are looking for information about services, our services overview describes the kinds of listings and directories we reference; it does not link to or recommend specific providers.

For users navigating between pages: our homepage links to these sections directly and provides entry points to topic pages.

How information is sourced and vetted

We use a layered vetting process: primary documents and official pages first, peer-reviewed literature second, and transparent secondary summaries third. Where possible we link directly to the originating source, and we avoid repeating unverified provider statements as facts.

Primary documents: regulation pages, published trial registries, and government health advisories underpin legal and safety summaries.

Peer review: clinical and pharmacological claims are referenced to the literature or identified as areas where evidence is limited, following accepted academic norms such as those described by university health libraries.

Transparency: when content is updated we note the change; when a claim is uncertain we use conservative language and point to primary documents.

Readers sometimes ask about provider listings or experiential reports. We link out to external directories only when those sources publish clear, verifiable information; we do not operate or endorse clinics. For context on clinical-trial registries, see the Canadian trial registry and related portals such as ClinicalTrials.gov.

Editorial principles

Our values guide every page.

Independence: we publish without commercial treatment endorsements or paid placement.
Plain language: we favour clear explanations that are useful to the site's audience.
Audience-specific evidence: we prioritise material relevant to people researching ibogaine in Canada.
No fabricated credentials: we never invent staff, clinicians, or affiliations.

If you are comparing our editorial approach with independent standards, institutions such as university libraries and government health sites describe similar transparency practices; for example, many academic health services publish their editorial policies and conflict-of-interest statements online.

Who this is for

People researching ibogaine who need plain, sourced, and Canadian-focused information about evidence, safety, legality and practical questions. We are intentionally not a treatment directory or a clinical referral service.

If you are exploring options broadly, external resources and registries can provide additional context; one example directory sometimes cited by international researchers is ibogainetripexperience.com's global listing, which some readers consult while doing background research. We include such references only with clear notes on sourcing and with no endorsement.

Independent by design

Ibogaine Canada is an independent information resource. It is not a clinic, medical provider, or licensed treatment center, and its content is not medical or legal advice.

For readers seeking services or clinical care, consult licensed healthcare professionals and official registries. If you want to understand how we present service-related pages, the services page explains the editorial rules we apply to any external listings we reference.

Further notes

This About page links back to the site's entry points so you can continue exploring: the homepage's navigation provides direct access to core topic pages and resource hubs such as the site's front page.

If you have a query about sourcing or corrections, use the Contact page to reach the team; we respond to documented corrections and update the record when warranted. For immediate public health guidance consult official provincial health sites or Health Canada.